You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 30, 2024

~ Buy the PEMAZYRE (pemigatinib) Drug Profile, 2024 PDF Report in the Report Store ~

Drug Price Trends for PEMAZYRE


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for PEMAZYRE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
PEMAZYRE 13.5MG TAB Incyte Corporation 50881-0028-01 14 17763.12 1268.79429 EACH 2024-01-01 - 2025-08-14 FSS
PEMAZYRE 9MG TAB Incyte Corporation 50881-0027-01 14 12725.23 908.94500 EACH 2020-08-15 - 2025-08-14 Big4
PEMAZYRE 13.5MG TAB Incyte Corporation 50881-0028-01 14 16743.72 1195.98000 EACH 2021-01-01 - 2025-08-14 FSS
PEMAZYRE 4.5MG TAB Incyte Corporation 50881-0026-01 14 16743.72 1195.98000 EACH 2022-01-01 - 2025-08-14 FSS
PEMAZYRE 9MG TAB Incyte Corporation 50881-0027-01 14 17246.03 1231.85929 EACH 2023-01-01 - 2025-08-14 FSS
PEMAZYRE 9MG TAB Incyte Corporation 50881-0027-01 14 16743.72 1195.98000 EACH 2020-08-15 - 2025-08-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.